Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (691)	6/19/2002 9:43:42 AM
From: Jibacoa	Read Replies (1) \| Respond to of 1005

Of the entire portfolio KOSN & TELK are the only ones remaining on the green.And of those two TELK looks somewhat better.<g> INGN is up 15.57% today on the news , but only 2,700 shares have been traded.<g> "The discovery of how MDA-7/IL-24 works to regulate the immune system indicates that INGN 241, by helping the body to produce the protein, may have the potential to kill cancer cells via apoptosis while simultaneously stimulating the immune system by virtue of cytokine activity," said Sunil Chada, Ph.D., Introgen's director of research and development. This new insight suggests that INGN 241, which contains the mda-7 gene delivered in an adenoviral vector, might have the potential to be used both to treat primary lesions as well as metastatic disease. biz.yahoo.com It seems it is going to be again another not too good day for the general market. RAGL Bernard